Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast Cancer.

ABSTRACT: This retrospective study examined magnetic resonance imaging (MRI)-derived tumor sphericity (SPH) as a quantitative measure of breast tumor morphology, and investigated the association between SPH and reader-assessed morphological pattern (MP). In addition, association of SPH with pathologic complete response was evaluated in patients enrolled in an adaptively randomized clinical trial designed to rapidly identify new agents for breast cancer. All patients underwent MRI examinations at multiple time points during the treatment. SPH values from pretreatment (T0) and early-treatment (T1) were investigated in this study. MP on T0 dynamic contrast-enhanced MRI was ranked from 1 to 5 in 220 patients. Mean SPH values decreased with the increased order of MP. SPH was higher in patients with patho

SUBMITTER: Li W 

PROVIDER: S-EPMC7289243 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature